NVX-CoV2601 (35μg)

Drug identity checked against registry records

Also recorded as Omicron XBB.1.5

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS VaccinesNCT05925127NovavaxPhase 2, Phase 3Completed2024-05-21Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.